Carregant...
Beyond PD-1 Immunotherapy in Malignant Melanoma
For many years, the standard therapy for malignant melanoma was based mainly on surgical resection. Unfortunately, this treatment is curative only in the early localized stage of this malignancy. The metastatic stage of malignant melanoma still remains a huge therapeutic challenge. Despite the many...
Guardat en:
| Publicat a: | Dermatol Ther (Heidelb) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522569/ https://ncbi.nlm.nih.gov/pubmed/30927248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-0292-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|